Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: an Italian consensus paper and critical review

Triple-negative (TN) breast cancer (BC) definition relies on immunohistochemistry (IHC) and in situ hybridization (ISH) assessment and refers to the absence of hormone receptor (HR) expression (estrogen receptor [ER] and progesterone receptor [PgR] expression
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Source Type: research